Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma.
Montemagno C, Cassim S, Trichanh D, Savary C, Pouyssegur J, Pagès G, Fagret D, Broisat A, Ghezzi C. Montemagno C, et al. Cancers (Basel). 2019 Oct 10;11(10):1531. doi: 10.3390/cancers11101531. Cancers (Basel). 2019. PMID: 31658755 Free PMC article.
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer.
Montemagno C, Dumas L, Cavaillès P, Ahmadi M, Bacot S, Debiossat M, Soubies A, Djaïleb L, Leenhardt J, Leiris N, Dufies M, Pagès G, Hernot S, Devoogdt N, Perret P, Riou L, Fagret D, Ghezzi C, Broisat A. Montemagno C, et al. Cancers (Basel). 2019 Jul 23;11(7):1039. doi: 10.3390/cancers11071039. Cancers (Basel). 2019. PMID: 31340603 Free PMC article.
Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer.
Montemagno C, Bacot S, Ahmadi M, Kerfelec B, Baty D, Debiossat M, Soubies A, Perret P, Riou L, Fagret D, Broisat A, Ghezzi C. Montemagno C, et al. J Nucl Med. 2018 Jul;59(7):1056-1062. doi: 10.2967/jnumed.117.203489. Epub 2018 Mar 23. J Nucl Med. 2018. PMID: 29572256 Free article.
LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers.
Prunier C, Josserand V, Vollaire J, Beerling E, Petropoulos C, Destaing O, Montemagno C, Hurbin A, Prudent R, de Koning L, Kapur R, Cohen PA, Albiges-Rizo C, Coll JL, van Rheenen J, Billaud M, Lafanechère L. Prunier C, et al. Among authors: montemagno c. Cancer Res. 2016 Jun 15;76(12):3541-52. doi: 10.1158/0008-5472.CAN-15-1864. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216191 Free article.
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.
Montemagno C, Cassim S, Pouyssegur J, Broisat A, Pagès G. Montemagno C, et al. Int J Mol Sci. 2020 Jun 6;21(11):4067. doi: 10.3390/ijms21114067. Int J Mol Sci. 2020. PMID: 32517181 Free PMC article. Review.
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1-5 SPECT in ApoE-/- Mice Fed the Paigen Diet.
Dumas LS, Briand F, Clerc R, Brousseau E, Montemagno C, Ahmadi M, Bacot S, Soubies A, Perret P, Riou LM, Devoogdt N, Lahoutte T, Barone-Rochette G, Fagret D, Ghezzi C, Sulpice T, Broisat A. Dumas LS, et al. Among authors: montemagno c. J Nucl Med. 2017 Jul;58(7):1088-1093. doi: 10.2967/jnumed.116.177279. Epub 2017 Mar 9. J Nucl Med. 2017. PMID: 28280218 Free article.
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
de Leiris N, Leenhardt J, Boussat B, Montemagno C, Seiller A, Phan Sy O, Roux J, Laramas M, Verry C, Iriart C, Fiard G, Long JA, Descotes JL, Vuillez JP, Riou L, Djaileb L. de Leiris N, et al. Among authors: montemagno c. Cancer Imaging. 2020 Aug 12;20(1):58. doi: 10.1186/s40644-020-00333-y. Cancer Imaging. 2020. PMID: 32787923 Free PMC article.
Feedback